TXG insider transactions
10x Genomics Inc. (TXG) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for TXG
- Director Teichmann Sarah A. was granted 8,829 shares, increasing direct ownership by 33% to 35,609 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Director Suliman Shehnaaz was granted 8,829 shares, increasing direct ownership by 31% to 37,445 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Director Stuelpnagel John R was granted 8,829 shares, increasing direct ownership by 2% to 368,436 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Director Popovits Kimberly J was granted 8,829 shares, increasing direct ownership by 31% to 37,445 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Director Mateo Alan was granted 8,829 shares, increasing direct ownership by 11% to 85,877 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Director Kosaraju Sridhar was granted 8,829 shares, increasing direct ownership by 16% to 65,278 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Executive Officer Saxonov Serge sold $709,057 worth of shares (28,893 units at $24.54) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,138,380 units (SEC Form 4) to satisfy withholding tax4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Officer Hindson Benjamin J. sold $283,399 worth of shares (11,595 units at $24.44), decreasing direct ownership by 2% to 502,000 units (SEC Form 4) to satisfy tax liability4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Financial Officer Taich Adam sold $369,018 worth of shares (15,098 units at $24.44), decreasing direct ownership by 4% to 379,898 units (SEC Form 4) to cover taxes4 - 10x Genomics, Inc. (0001770787) (Issuer)
- SEC Form 4 filed by Saxonov Serge4 - 10x Genomics, Inc. (0001770787) (Issuer)
- SEC Form 4 filed by Saxonov Serge4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Executive Officer Saxonov Serge gifted 2,750 shares and sold $367,097 worth of shares (16,152 units at $22.73), decreasing direct ownership by 2% to 1,200,917 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Executive Officer Saxonov Serge was granted 157,895 shares, increasing direct ownership by 15% to 1,219,819 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Officer Hindson Benjamin J. was granted 88,816 shares, increasing direct ownership by 21% to 513,595 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Financial Officer Taich Adam was granted 106,579 shares, increasing direct ownership by 37% to 394,996 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Director Teichmann Sarah A. sold $147,108 worth of shares (7,579 units at $19.41), decreasing direct ownership by 22% to 26,780 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Executive Officer Saxonov Serge sold $178,928 worth of shares (9,632 units at $18.58), decreasing direct ownership by 0.90% to 1,061,924 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Financial Officer Taich Adam sold $166,593 worth of shares (8,968 units at $18.58), decreasing direct ownership by 3% to 288,417 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Officer Hindson Benjamin J. sold $145,379 worth of shares (7,826 units at $18.58), decreasing direct ownership by 2% to 424,779 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Executive Officer Saxonov Serge exercised 50,000 shares at a strike of $1.20, increasing direct ownership by 5% to 1,071,556 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Financial Officer Taich Adam sold $225,852 worth of shares (11,888 units at $19.00), decreasing direct ownership by 4% to 297,385 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Officer Hindson Benjamin J. sold $157,363 worth of shares (8,283 units at $19.00), decreasing direct ownership by 2% to 432,605 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Executive Officer Saxonov Serge sold $251,936 worth of shares (13,261 units at $19.00), decreasing direct ownership by 1% to 1,021,556 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Executive Officer Saxonov Serge gifted 900 shares, decreasing direct ownership by 0.09% to 1,034,817 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Executive Officer Saxonov Serge sold $128,881 worth of shares (9,348 units at $13.79), decreasing direct ownership by 0.98% to 945,892 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Financial Officer Taich Adam sold $307,657 worth of shares (22,315 units at $13.79), decreasing direct ownership by 7% to 309,273 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Officer Hindson Benjamin J. sold $103,209 worth of shares (7,486 units at $13.79), decreasing direct ownership by 2% to 440,888 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Executive Officer Saxonov Serge gifted 1,000 shares, decreasing direct ownership by 0.10% to 955,240 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Director Teichmann Sarah A. was granted 15,357 shares, increasing direct ownership by 81% to 34,359 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Director Suliman Shehnaaz was granted 15,357 shares, increasing direct ownership by 116% to 28,616 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Director Stuelpnagel John R was granted 15,357 shares, increasing direct ownership by 4% to 359,607 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Director Popovits Kimberly J was granted 15,357 shares, increasing direct ownership by 116% to 28,616 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Director Mateo Alan was granted 15,357 shares, increasing direct ownership by 25% to 77,048 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Director Kosaraju Sridhar was granted 15,357 shares, increasing direct ownership by 37% to 56,449 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Executive Officer Saxonov Serge gifted 3,000 shares, decreasing direct ownership by 0.28% to 1,080,625 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Executive Officer Saxonov Serge sold $77,540 worth of shares (9,343 units at $8.30), decreasing direct ownership by 0.85% to 1,083,625 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Officer Hindson Benjamin J. sold $62,120 worth of shares (7,485 units at $8.30), decreasing direct ownership by 2% to 448,374 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Financial Officer Taich Adam sold $33,562 worth of shares (4,044 units at $8.30), decreasing direct ownership by 1% to 331,588 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Executive Officer Saxonov Serge was granted 171,428 shares, increasing direct ownership by 19% to 1,092,968 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Officer Hindson Benjamin J. was granted 120,535 shares, increasing direct ownership by 36% to 455,859 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Financial Officer Taich Adam was granted 335,632 shares (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Executive Officer Saxonov Serge sold $84,393 worth of shares (7,942 units at $10.63) and exercised 50,000 shares at a strike of $1.20, increasing direct ownership by 5% to 921,540 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Officer Hindson Benjamin J. sold $50,603 worth of shares (4,573 units at $11.07), decreasing direct ownership by 1% to 335,324 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Executive Officer Saxonov Serge sold $56,346 worth of shares (5,092 units at $11.07), decreasing direct ownership by 0.58% to 879,482 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Director Mateo Alan bought $445,572 worth of shares (40,000 units at $11.14), increasing direct ownership by 184% to 61,691 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Executive Officer Saxonov Serge exercised 12,000 shares at a strike of $1.20, increasing direct ownership by 1% to 884,574 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Executive Officer Saxonov Serge gifted 1,850 shares and sold $91,612 worth of shares (6,693 units at $13.69), decreasing direct ownership by 0.97% to 872,574 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Officer Hindson Benjamin J. sold $79,485 worth of shares (5,807 units at $13.69), decreasing direct ownership by 2% to 339,897 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Executive Officer Saxonov Serge gifted 1,350 shares, decreasing direct ownership by 0.15% to 881,117 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Director Teichmann Sarah A. was granted 19,002 shares (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Chief Executive Officer Saxonov Serge sold $152,053 worth of shares (6,749 units at $22.53), decreasing direct ownership by 0.76% to 882,467 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Officer Hindson Benjamin J. sold $98,027 worth of shares (4,351 units at $22.53), decreasing direct ownership by 1% to 345,704 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Former Chief Financial Officer Mcanear Justin J. sold $66,710 worth of shares (2,961 units at $22.53), decreasing direct ownership by 2% to 143,242 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- SEC Form 3 filed by new insider Taich Adam3 - 10x Genomics, Inc. (0001770787) (Issuer)
- Director Mateo Alan was granted 21,691 shares (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- SEC Form 3 filed by new insider Teichmann Sarah A.3 - 10x Genomics, Inc. (0001770787) (Issuer)
- SEC Form 3 filed by new insider Mateo Alan3 - 10x Genomics, Inc. (0001770787) (Issuer)
- Director Stuelpnagel John R was granted 8,649 shares, increasing direct ownership by 3% to 344,250 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Director Kosaraju Sridhar was granted 8,649 shares, increasing direct ownership by 27% to 41,092 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)
- Director Popovits Kimberly J was granted 8,649 shares, increasing direct ownership by 188% to 13,259 units (SEC Form 4)4 - 10x Genomics, Inc. (0001770787) (Issuer)